Results
2533
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,533 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$877.79 | -4.7% | 63.4% | US$790.4b | US$995.42 | PE107.6x | E28.5% | 0.6% | Pharmaceuticals & Biotech | ||
UNH | US$581.85 | 1.2% | 15.4% | US$537.3b | US$623.11 | PE38.1x | E23.4% | 1.4% | Healthcare | ||
JNJ | US$161.40 | -1.7% | 3.6% | US$388.5b | US$171.32 | PE23.7x | E7.2% | 3.1% | Pharmaceuticals & Biotech | ||
ABBV | US$194.79 | 0.7% | 30.7% | US$344.1b | US$196.54 | PE64.9x | E25.3% | 3.2% | Pharmaceuticals & Biotech | ||
MRK | US$113.69 | -3.0% | 10.4% | US$288.2b | US$139.03 | PE21x | E14.4% | 2.7% | Pharmaceuticals & Biotech | ||
AZN | UK£116.54 | -1.1% | 5.0% | UK£180.7b | UK£138.09 | PE37.5x | E16.4% | 1.9% | Pharmaceuticals & Biotech | ||
TMO | US$614.42 | 0.1% | 21.4% | US$234.7b | US$647.76 | PE37.7x | E10.6% | 0.3% | Pharmaceuticals & Biotech | ||
DHR | US$275.44 | 1.0% | 11.0% | US$198.9b | US$288.05 | PE49x | E14.3% | 0.4% | Pharmaceuticals & Biotech | ||
ABT | US$112.43 | -1.1% | 16.1% | US$195.6b | US$124.12 | PE35.3x | E11.7% | 2.0% | Healthcare | ||
AMGN | US$322.67 | -4.4% | 20.1% | US$173.4b | US$325.55 | PE55.4x | E23.8% | 2.8% | Pharmaceuticals & Biotech | ||
ISRG | US$479.18 | -1.4% | 63.9% | US$170.3b | US$483.95 | PE81.3x | E12.5% | n/a | Healthcare | ||
PFE | US$29.09 | -1.1% | -12.3% | US$164.8b | US$33.56 | PS3x | E32.5% | 5.8% | Pharmaceuticals & Biotech | ||
SYK | US$360.27 | -1.2% | 31.8% | US$137.3b | US$372.59 | PE39.8x | E10.8% | 0.9% | Healthcare | ||
BSX | US$83.35 | -0.7% | 57.9% | US$122.7b | US$87.26 | PE67.1x | E20.9% | n/a | Healthcare | ||
ELV | US$523.95 | -2.9% | 20.3% | US$121.5b | US$603.07 | PE18.2x | E11.6% | 1.2% | Healthcare | ||
VRTX | US$462.88 | -0.4% | 33.1% | US$119.5b | US$509.82 | PS11.6x | E46.4% | n/a | Pharmaceuticals & Biotech | ||
MDT | US$89.32 | -0.02% | 14.0% | US$114.6b | US$94.62 | PE29.2x | E11.2% | 3.1% | Healthcare | ||
REGN | US$1,042.69 | -8.9% | 26.7% | US$112.5b | US$1,157.67 | PE26x | E10.5% | n/a | Pharmaceuticals & Biotech | ||
GILD | US$83.61 | -0.4% | 11.6% | US$104.1b | US$83.54 | PE98.8x | E36.0% | 3.7% | Pharmaceuticals & Biotech | ||
HCA | US$403.28 | -0.3% | 63.9% | US$104.1b | US$396.60 | PE18.1x | E6.3% | 0.7% | Healthcare | ||
BMY | US$50.91 | 3.0% | -12.3% | US$103.2b | US$53.86 | PS2.2x | E49.0% | 4.7% | Pharmaceuticals & Biotech | ||
CI | US$347.70 | -2.4% | 21.5% | US$97.2b | US$398.29 | PE26.2x | E19.4% | 1.6% | Healthcare | ||
CSL | AU$285.10 | -2.9% | 13.7% | AU$138.0b | AU$312.07 | PE36.1x | E13.0% | 1.3% | Pharmaceuticals & Biotech | ||
ZTS | US$194.81 | 1.1% | 12.0% | US$88.3b | US$213.12 | PE37.7x | E10.2% | 0.9% | Pharmaceuticals & Biotech |